Diabetes and COVID-19

 View Only
  • 1.  Incidence of T1 DM during the COVID-19 Pandemic

    Posted 08-11-2022 10:14

    A debate rages on about whether the SARS-CoV-2 virus infection can give rise to new-onset diabetes. An apparent increase in the incidence of pediatric type 1 diabetes was seen early in the COVID-19 pandemic. The German Diabetes Prospective Follow-Up Registry now has a substantial observation period to look at this question, and the paper in this month's Diabetes Care confirms a significant increase (covering Jan 2020 to June 2021, IRR 1.15). The authors surmise, however, that indirect factors (because of the environmental changes resulting from the pandemic), rather than direct diabetogenic actions of the virus, might be playing a major role.

     

    https://diabetesjournals.org/care/article/45/8/1762/139385/Incidence-of-Type-1-Diabetes-in-Children-and



    ------------------------------
    Ali Rizvi, MD
    UCF College of Medicine
    Orlando, FL
    ------------------------------


  • 2.  RE: Incidence of T1 DM during the COVID-19 Pandemic

    Posted 08-15-2022 20:29

    Dear Ali,

    Thank you for highlighting the DPV study. I would like to share our U.S. multi-center T1D Exchange study exploring a similar question.

    The T1D Exchange Quality Improvement Collaborative (T1DX-QI) coordinated this study. We found a 9% increase in newly diagnosed cases in the early pandemic. Our study also highlighted an increased DKA presentation among newly diagnosed T1D patients during the early COVID19 surge. These findings were in line with the German DPV study with similar conclusions that environmental changes and the "lockdown" effects might be major contributors to the increased incidence.

    You can read more about the study published in Pediatric Diabetes
    https://doi.org/10.1111/pedi.13328

    We plan to conduct larger longitudinal studies using our center EMR database and hope to share additional insights on this topic in the future.

    ------------------------------
    Osagie Ebekozien MD, MPH, CPHQ
    Chief Medical Officer
    T1D Exchange
    Boston
    ------------------------------